Cite
HARVARD Citation
Neven, P. et al. (n.d.). 1850 Safety of everolimus plus exemestane in elderly patients with Hormone-Receptor-Positive (HR+), HER2- locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors (NSAIs): BALLET (CRAD001YIC04). European journal of cancer. pp. S282-. [Online].